BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2019
View Archived Issues
Aspartylglycosamine as a potential new biochemical marker of NGLY1-CDDG
Read More
Imotope shows promise in EAE model
Read More
Methylation patterns, AI identify metastases
Read More
Mitochondria differ between cell types
Read More
EGPI-1 as a promising new anticancer agent that targets the eIF4E/eIF4G interface
Read More
p38Gamma as a novel therapeutic target in human colorectal cancer
Read More
Waking up sleeping Xs
Read More
Enrollment initiated in phase III study of NmCV-5
Read More
First volunteers dosed in phase I clinical program of IMU-935
Read More
Results presented from AFIRE study of rivaroxaban monotherapy versus combination therapy
Read More
Identification of a novel Mtb inhibitor BRD-8000.3 through large-scale chemical-genetics platform
Read More
Sichuan University reports phase I results for yogliptin
Read More
D-578 demonstrates antidepressant and anti-PTSD-like effects in vivo
Read More
Study finds microbe drives CRC, identifies therapeutic target
Read More
First-in-human study evaluates UB-312 in healthy subjects and patients with Parkinson's disease
Read More
Heidelberg Pharma's work in ETN MAGICBULLET project supported by new E.U. grant
Read More
Molecular Templates begins first-in-human study of MT-5111 in HER2-positive solid tumors
Read More
U.S. researchers patent HLA DQ8 ligands
Read More
SciFluor Life Sciences presents new integrin receptor antagonists
Read More
Genentech identifies new SCN9A blockers
Read More
Karus Therapeutics describes HDAC inhibitors
Read More
New cytokine biosynthesis inducers presented by 3M Pharmaceuticals
Read More
Onxeo reports initial data from first part of phase Ib DRIIV study of AsiDNA
Read More
Alzprotect cleared to begin French phase IIa trial of AZP-2006 in progressive supranuclear palsy
Read More
BeiGene studies BGB-A1217 with tislelizumab in advanced solid tumors
Read More